Market Tracker

12/19 11:01pm ET

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

118.90
Data as of Dec 19
 +1.16 / +0.99%
Today’s Change
59.79
Today|||52-Week Range
124.35
+60.03%
Year-to-Date

Today’s Trading

Previous close117.74
Today’s open117.25
Day’s range116.76 - 124.35
Volume6,131,369
Average volume (3 months)1,739,473
Market cap$28.6B
Dividend yield--
Data as of 4:14pm ET, 12/19/2014

Growth & Valuation

Earnings growth (last year)-296.00%
Earnings growth (this year)-50.54%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)-20.63%
P/E ratioNM
Price/Sales13.79
Price/Book20.49

Competitors

 Today’s
change
Today’s
% change
PRGOPerrigo Company PLC+3.29+2.00%
ZTSZoetis Inc+0.36+0.83%
MYLMylan Inc+0.68+1.20%
ALXNAlexion Pharmaceutic...+0.57+0.30%
Data as of 4:14pm ET, 12/19/2014

Financials

Next reporting dateFebruary 5, 2015
EPS forecast (this quarter)-$0.69
Annual revenue (last year)$1.2B
Annual profit (last year)-$445.0M
Net profit margin-36.72%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeff M. Leiden
Chief Financial Officer &
Executive Vice President
Ian F. Smith
Corporate headquarters
Cambridge, Massachusetts

Forecasts